The Morning Brief cover image

Cipla Saga - Did The Doctor Prescribe A Sale?

The Morning Brief

00:00

Sipla's Speculated Sale Is Not Just a M&A Deal

There is a very clear national pride here because of what Sipla did as an Indian institution and as a reliable supplier of medicines within India and low income countries. 20 years ago Sipla was absolutely at the international headlines for taking a combative role against global companies to break their patterns. Dr. Yuzhu Famil said that we can offer AIDS cocktail therapies for the entire year for 350 dollars against a $12,000 which was being charged by global companies at that time.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app